Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.
At Allergan, there is no shortage of projects, strategies and initiatives to challenge, inspire and engage individuals at all levels.
Today, our talented global employees are creating an unrivalled foundation for long-term growth. We combine highly regarded brands with an enviable pipeline and lean, reliable operations to drive value for customers.
Allergan Clinical Trials
Allergan has a rich and promising pipeline of new therapeutics and innovative technologies in specialty areas including eye care, neurosciences, medical aesthetics, medical dermatology, and urologics. We focus on novel therapies with the power to advance treatment paradigms and have numerous compounds in various stages of clinical development.
Clinical trials are research studies intended to answer scientific questions and find better ways to treat or prevent diseases. They are fundamental to the development of innovative medicines and devices that treat and prevent illness. Clinical trials are possible because volunteers (healthy volunteers and patients) agree to participate and try new medicines and devices.